None listed
Conditions
Interventions
Radiation : Equivalent dose in 2 Gy irradiation using linear-quadratic model [surviving fraction = exp-1(aD + ßD2)] is mainly used to compare the relative doses between radiation treatments of various
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: - Patients with histologically diagnosed prostate cancer - Prostate cancer of medium risk groups or higher according to the National Comprehensive Cancer Network (NCCN) guidelines - Adults over 20. - Biochemical recurrence after surgery (Definitions: PSA >0.2 ng/mL, =1.0 ng/mL) - Full body performance ECOG 0-1 - Finding suitable haematological examination within 6 months prior to research registration Absolute neutrophil count (ANC) = 1500 cells/mm3 Platelets = 50,000 cells/mm3 Hemoglobin = 8.0 g/dl - Adequate kidney function within 6 months of study registration Creatine < 2.0 ng/dL - Appropriate liver function within 6 months of research registration total bilirubin < 1.5 X normal maximum alignin aminotransferase or aspartate aminotransferase < 2.5 X normal maximum - preSRT PSA = 1 ng/mL
Exclusion criteria
Exclusion criteria: - Imaging examination of surgical site or clinically identified recurrent findings - If pelvic lymph node transfer is confirmed - If teleconversion is confirmed - In case anti-cancer treatment is performed prior to surgery - Past history of exposure to pelvic radiation - Crucial force that has been treated for prostate cancer in cold treatment and near-field radiation - If treated with cancer other than skin cancer and thyroid cancer, NED f/u can be registered after treatment of existing cancer for more than 5 years - In case of severe shared disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PSA and Toxicity assessment are conducted every week during radiation treatment period for five years after examination and end of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Expanded prostate cancer index composite(EPIC),EORTC QLQ-C30 | — |
Countries
Korea, Republic of
Contacts
Public ContactKim Seok
Asan Medical Center
Outcome results
None listed